ZHOU; Jiehua

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZHOU; Jiehua.The latest application filed is for "ccr7 aptamers and uses thereof".

Company Profile

3.12.11

ZHOU; Jiehua - Monrovia CA
Zhou; Jiehua - Duarte CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ccr7 Aptamers And Uses Thereof App 20210330692 - ROSSI; John J. ; et al.	2021-10-28
CCR7 aptamers and uses thereof Grant 11,007,211 - Rossi , et al. May 18, 2	2021-05-18
Ccr7 Aptamers And Uses Thereof App 20190262383 - ROSSI; John ; et al.	2019-08-29
Cell-specific internalizing RNA aptamers against human CCR5 and uses therefore Grant 10,167,474 - Rossi , et al. J	2019-01-01
Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy Grant 10,041,071 - Rossi , et al. August 7, 2	2018-08-07
Cell-specific Internalizing Rna Aptamers Against Human Ccr5 And Uses Therefore App 20180080026 - Rossi; John ; et al.	2018-03-22
RNA aptamers against BAFF-R as cell-type specific delivery agents and methods for their use Grant 9,695,425 - Rossi , et al. July 4, 2	2017-07-04
Cell-specific internalizing RNA aptamers against human CCR5 and uses therefore Grant 9,605,266 - Rossi , et al. March 28, 2	2017-03-28
CELL-TYPE SPECIFIC APTAMER-siRNA DELIVERY SYSTEM FOR HIV-1 THERAPY App 20170073684 - Rossi; John J. ; et al.	2017-03-16
Rna Aptamers Against Baff-r As Cell-type Specific Delivery Agents And Methods For Their Use App 20160348113 - ROSSI; John ; et al.	2016-12-01
Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy Grant 9,506,064 - Rossi , et al. November 29, 2	2016-11-29
RNA aptamers against BAFF-R as cell-type specific delivery agents and methods for their use Grant 9,353,374 - Rossi , et al. May 31, 2	2016-05-31
Rna Aptamers Against Baff-r As Cell-type Specific Delivery Agents And Methods For Their Use App 20160076036 - ROSSI; John ; et al.	2016-03-17
Cell-specific Internalizing Rna Aptamers Against Human Ccr5 And Uses Therefore App 20160053265 - Rossi; John ; et al.	2016-02-25
CELL-TYPE SPECIFIC APTAMER-siRNA DELIVERY SYSTEM FOR HIV-1 THERAPY App 20150368645 - Rossi; John J. ; et al.	2015-12-24
Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy Grant 9,163,241 - Rossi , et al. October 20, 2	2015-10-20
RNA aptamers against BAFF-R as cell-type specific delivery agents and methods for their use Grant 9,006,416 - Rossi , et al. April 14, 2	2015-04-14
Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy Grant 8,222,226 - Rossi , et al. July 17, 2	2012-07-17
CELL-TYPE SPECIFIC APTAMER-siRNA DELIVERY SYSTEM FOR HIV-1 THERAPY App 20110318838 - Rossi; John J. ; et al.	2011-12-29
Cell-type specific aptamer-siRNA delivery system for HIV-1 Therapy Grant 8,030,290 - Rossi , et al. October 4, 2	2011-10-04
CELL-TYPE SPECIFIC APTAMER-siRNA DELIVERY SYSTEM FOR HIV-1 THERAPY App 20110217769 - Rossi; John J. ; et al.	2011-09-08
CELL-TYPE SPECIFIC APTAMER-siRNA DELIVERY SYSTEM FOR HIV-1 THERAPY App 20090148944 - Rossi; John J. ; et al.	2009-06-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.